Advamedica Inc announces FDA clearance for Ax-Surgi Surgical Hemostat

CAMBRIDGE, Mass., March 20, 2023 /PRNewswire/ — Advamedica Inc., a biomaterial focused medtech startup today announced the US Food and Drug Administration (FDA) 510(k) clearance for its latest innovation, Ax-Surgi Surgical Hemostat. With this, Ax-Surgi has become first and only chitosan…